Xinxin Li

Xinxin Li is a seasoned professional in the field of biologics, currently serving as Senior Director of Analytical and Formulation at 先声药业 since January 2017, following a progressive career that includes a role as Director of Analytical and Formulation Development. Xinxin has established key platforms for protein characterization and formulation development, oversees various aspects of biologics characterization and testing, and has contributed to regulatory projects including a BLA submission. Prior experience includes management positions at Jiangsu Hengrui Medicine Co., Ltd., where leadership was demonstrated in antibody characterization and stability testing, as well as roles at Viva Biotech Ltd and WuXi AppTec focusing on protein research and development. Xinxin holds a Postdoctoral degree from the University of Pennsylvania, a Ph.D. in Biological Chemistry and Molecular Biology, and a B.S. in Chemistry from the University of Science and Technology of China.